Dr. Thomas H. Adams holds a Ph.D. in Biochemistry from the University of California, Riverside. Dr. Adams founded Gen-Probe, Inc. in 1983 and served as its Chief Executive Officer and Chairman until its acquisition by Chugai Biopharmaceuticals, Inc. in 198... Learn more »
Dr. Richard Anderson obtained a PhD in Chemistry from the University of California, Davis in 1979. From 1981-1984 he worked as a scientist at Bayer Diagnostics (Miles Laboratories). In 1984, Dr. Anderson began work with Hybritech in 1984 and then went on t... Learn more »
Richard C. Atkinson is president emeritus of the University of California and professor emeritus of cognitive science and psychology at the University of California, San Diego. He served as president of the UC system from 1995 to 2003; his tenure was marke... Learn more »
Knox Bell concentrates his legal practice in the areas of business and corporate, biotechnology and life sciences, licensing, strategic alliances, healthcare and nonprofit research institution. Source: DLA Piper website... Learn more »
Dr. Birndorf holds a Master of Science in Biochemistry degree from Wayne State University and has received honorary doctorates from both Wayne State University and Oakland University. Beginning in 1978, Dr. Birndorf worked with Hybritech Incorporated and h... Learn more »
Dr. James C. Blair, Jim, Ph.D., serves as a Partner of Domain Associates, L.L.C. Dr. Blair has been in this role since joining Domain on it’s founding in 1985. Dr. Blair has over 40 years experience with venture and emerging growth companies. He has ... Learn more »
Mr. Blickenstaff earned an MBA from Loyola University Chicago’s Graduate School of Business. He held various finance operations, research management, sales management, strategic planning and marketing positions with Hybritech Incorporated and Baxter ... Learn more »
Mr. Lawrence A. Bock is a Special Limited Partner at Lux Capital Management. Mr. Bock also founded the firm. He is a Co-Founder of Nanosys Inc. Previously, he was a Managing General Partner at CW Group, Inc. since June 1998. At CW Group, he managed the fir... Learn more »
Dr. Buechler received his doctorate in biochemistry and his bachelor’s degree in chemistry from Indiana University. Dr. Buechler was a senior research scientist for the Diagnostics Research and Development Group at Hybritech Incorporated in San Diego... Learn more »
Mr. Malin Burnham serves as the Chairman of John Burnham & Co. Mr. Burnham is a private investor. Mr. Burnham serves as the Chairman of Burnham Pacific Properties and Chairman of Advisory Council of Sorrento Associates, Inc. He is the Founder of First Nati... Learn more »
Dr. Brook H. Byers, Ph.D., is a Partner at KPCB Digital Growth Fund, L.P., Kleiner Perkins Caufield & Byers XI, L.P., Kleiner Perkins Caufield & Byers XII, L.P., Kleiner Perkins Caufield & Byers XIII, L.P. and KPCB Information Sciences Zaibatsu Fund II, L.... Learn more »
Mr. Cohen received degrees in biology and chemistry from Dartmouth College and an MBA from the Wharton School of The University of Pennsylvania. Mr. Cohen began his career at Eli Lilly and Company in 1978, where, among many different responsibilities over ... Learn more »
Dr. Comer received a B.A. in Chemistry from Carleton College in 1957, and a Ph.D. in Organic Chemistry, Pharmacology from the University of Iowa in 1961. From 1961-1991 he was employed by Mead Johnson & Co. which was acquired by Bristol-Myers; he was respo... Learn more »
Mr. Cramer is best known as the entrepreneur who founded Ivac and Imed, two major manufacturers of medical infusion pumps. Mr. Cramer founded Ivac in 1967, but later was forced out in a proxy fight. He founded Imed in 1972. In 1982, Mr. Cramer sold the com... Learn more »
Mr. Crawford earned a bachelor’s degree in mathematical sciences from Stanford University and an MBA from the University of Chicago’s Graduate School of Business. Over the course of his career, Mr. Crawford has been a consultant, executive offi... Learn more »
After receiving his PhD in biochemistry from UCLA in 1979, Dr. Walter Desmond went to work for Hybritech for over twenty years, where he contributed to the development of TANDEM and ICON technologies and other important developments. He went on to work in ... Learn more »
Dr. Dobak received his Bachelor’s Degree from UCLA and his M.D. from the UC, San Diego in 1992. He went on to serve as Chief Executive Officer with CryoCor, and Chief Executive Officer and founder of Intercool where he was a co-inventor of Intercool&... Learn more »
Ms. Dunham received a Bachelor’s degree in chemistry from Rutgers University and an MBA in production management from San Diego State University. Born in Dover, NJ in 1945, Jeanne M. Dunham passed away in her sleep in May 2010. A longtime Mission Hil... Learn more »
Peter Farrell is founder and chairman of the board of ResMed and has been a director and chairman of the board since its inception in June 1989. He served as chief executive officer from July 1990 until December 2007 and from February 2011 until March 2013... Learn more »
Dr. Felgner received his PhD in Biochemistry/Neuroscience from Michigan State University in 1978 and also completed Postdoctoral training in Biophysics at University of Virginia. He has over 25 years of experience in the biotechnology industry, including s... Learn more »
A 27-year veteran of venture capital investing, Mr. Fleming has helped raise and manage six venture funds totaling more than $500 million and has served on the boards of 19 venture-backed companies. He has extensive experience in all aspects of venture man... Learn more »
Howard (Ted) Greene received a Bachelor of Arts in Physics from Amherst College and an MBA from Harvard University. Largely based in San Diego and retired to Michigan, his business career included founding or managing eleven medical technology companies. H... Learn more »
Dr. Hagan collaborated with Hybritech and its research as a radiopharmacist beginning in 1978 and was involved in cancer research until 1987. Dr. Hagan continued to work in nuclear medicine until 1997.... Learn more »
Dr. Halpern received his M.D. in 1962 from the University of Louisville School of Medicine and completed an internal medicine residence in 1968 at the University of Oklahoma. He worked with Hybritech beginning in 1970 as a consultant doing radiopharmaceuti... Learn more »
Guy Iannuzzi is a marketing executive with over 40 years of diversified experience in marketing, proficient in translating technologies into commercial success. Guy founded the agency Mentus in 1981, specializing in marketing and public relations for high ... Learn more »
Dr. Douglas Jolly was born in the United Kingdom and received a Ph.D in Biochemistry from the University of Glasgow. Before entering the biopharmaceutical industry, Dr. Jolly pursued his academic career in biophysics and molecular biology at the Weizmann I... Learn more »
Dr. Kabakoff earned his Bachelor of Arts in Chemistry from Case Western Reserve University, his Ph.D. in Organic Chemistry from Yale University, and post-doctoral research at the University of California San Diego. He held senior executive positions with S... Learn more »
Mr. Kevin J. Kinsella is the Founder and Managing Director at Avalon Ventures, LLC. He founded the firm in March 1983. He has specialized in the formation, financing and development of more than 125 early-stage companies, including: Athena Neurosciences O... Learn more »
Ms. Klause received her degree from the University of Virginia and has over 30 years of experience in the health care field. She began her career at Technicare Corporation, where she held a variety of senior positions, including Director of the MR Business... Learn more »
Dr. Laikind earned a PhD in Chemistry from UC, San Diego and has served as a research faculty member at the UC, San Diego School of Medicine. Dr. Laikind founded Gensia Inc. in 1986 and was Vice President of Business Development and a Director at Gensia wh... Learn more »
Dr. Marquet is co-Founder and co-CEO of ALMA Life Sciences LLC, an early stage investment firm focusing on the creation and growth of innovative health care companies with an overall focus on prevention. She is co-founder and co-Chairman of Althea (a membe... Learn more »
Frederick T. Muto is a founding partner of the firm's San Diego office, which opened in 1992. He has been with firm since 1980. The firm's San Diego office was recently named the #1 firm in San Diego as ranked by area corporate board members, according to... Learn more »
Dr. Nova holds a Bachelor of Science degree in Biological Sciences from the University of California, Irvine and a Ph.D. in Biochemistry from the University of California, Riverside. From 1994 to January 2000, Dr. Nova served as Chief Operating Officer and... Learn more »
Mr. Owen studied Industrial Engineering at the Georgia Institute of Technology and also obtained a degree in Business. He is a former U.S. Naval Officer and a veteran of two tours of duty in Vietnam. Prior to entering the health care industry, Mr. Owen wor... Learn more »
Joseph Panetta is President and CEO and a member of the Board of Directors of Biocom, California’s largest and most-experienced leader and advocate for the life science industry. Biocom works on behalf of more than 1,000 members to drive public... Learn more »
Mr. Payne received a Bachelor of Arts in Biology from UC, San Diego and then immediately went on to work more than 25 years with Hybritech, Inc. in various departments, including research and development, and regulatory affairs. He concurrently served at B... Learn more »
Dr. Rastetter holds a Bachelor of Science from MIT and earned a Masters and PhD degree in Chemistry from Harvard University. After leaving teaching on the East Coast, he joined Genentech Inc. (1982-1986), where he worked as a scientist and later as directo... Learn more »
Dr. Respess received a Bachelor of Science degree in Chemistry from Virginia Military Institute, obtained his J.D. from George Washington University, and earned a PhD in Organic Chemistry from MIT. He served as partner of Lyon & Lyon LLP, and Vice Presiden... Learn more »
Dr. Richman earned his Bachelor of Arts at Dartmouth College and his M.D. at Stanford University. He trained as an infectious disease physician and medical virologist at Stanford, the NIH and Harvard before joining the faculty at UC, San Diego in 1976. Dr.... Learn more »
Dr. Royston earned his Bachelor of Arts and M.D. degrees from Johns Hopkins University and completed post-doctoral training in Internal Medicine and Medical Oncology at Stanford University. He has been involved in the biotechnology industry in San Diego fr... Learn more »
Dr. Richard (Dick) S. Schneider obtained a Bachelor of Science in Chemistry from UC, Berkeley, attended the Stanford University School of Business, and obtained a Ph.D. in Organic Chemistry from University of Wisconsin. He completed his post-doctoral studi... Learn more »
Robert E. Sobol, M.D. has over 25 years of entrepreneur and management experience in the San Diego biotechnology community. Dr. Sobol has pioneered the development of novel biological cancer therapies in the fields of immune oncology and gene therapy. ... Learn more »
Mr. Ron Taylor received a Bachelor of Arts from University of Saskatchewan and a Master of Arts from UC, Irvine. He served in management roles at Allergan Pharmaceuticals and was responsible for the operations and international sales at Hybritech, Inc. Mr.... Learn more »
David Titus became President of the San Diego Venture Group (SDVG) in April 2011. He is also Managing Director of Windward Ventures, an early-stage venture fund focused on Southern California technology companies. Mr. Titus founded Windward ... Learn more »
Dr. Gunars E. Valkirs earned a PhD in Physics from UC, San Diego. Dr. Valkirs was a scientific investigator with the Diagnostics Research and Development Group at Hybritech Incorporated. During his tenure at Hybritech, he invented and developed the first r... Learn more »
Dr. Mary Lindenstein Walshok is a Member of Advisory Board at Finistere Partners, LLC. She is the Dean of the University Extension and Associate Vice Chancellor of Public Programs at the University of California, San Diego (UCSD). Dr. Walshok is responsibl... Learn more »
Dr. Robert Wang has served for more than 20 years in the biotechnology and biomedical device industries. He was Vice President of Pharmaceutical Operations for Genta Incorporated, Vice President of Product and Process Development for Gen-Probe Incorporated... Learn more »
Mr. Tim Wollaeger earned a B.A. in Economics from Yale, served as an officer in the U.S. Navy for three years, and earned an MBA from the Stanford University Graduate School of Business. He worked at Baxter International and at Hybritech, Inc., San Diego's... Learn more »